AstraZeneca AB v. Mylan Pharms. Inc.

Published date28 April 2021
Subject MatterPatents,AstraZeneca,Prescription Drugs,Generic Drugs,Patent-in-Suit,Patent Litigation,Pharmaceutical Patents,Mylan Pharmaceuticals,Patent Infringement,Pharmaceutical Industry
AuthorJeffrey Alan Hovden,Oren Langer,Christopher Pinahs,Kelsey McElveen,Haroon Mian
Law FirmRobins Kaplan LLP

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT